DAVION HEALTHCARE PLC (DAVI) Form 424B3 — Oct 13, 2026
Davion Healthcare Plc filed a prospectus supplement announcing a change of listing advisor and Lead Market Maker for its proposed Nasdaq direct listing under the symbol DAVI. Revere Securities LLC resigned from the listing advisor and Lead Market Maker roles, and Maxim Group LLC — already the company's non-exclusive financial advisor — has been appointed as replacement on identical contractual and remuneration terms. The supplement states there is no change to the direct listing structure, the 25,000,000 registered ordinary shares, opening auction arrangements, or the absence of a firm commitment underwriting, and the company will receive no proceeds from sales by registered shareholders.
Key figures
- Shares Offered
- 25000000
- Par Value
- EUR 0.01 per ordinary share
- Listing Type
- direct listing (no firm commitment underwriting)
- Listing Venue
- Nasdaq Global Market
- Company Proceeds
- Company will not receive any proceeds from sales by registered shareholders
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.